Invasive DTC is associated with age <10 years, male sex, tumors driven by oncogenic fusions and ETE. Despite less aggressive therapies in recent years, disease outcomes have not worsened. Recognition of these associations may guide care and prognostication.
Wasserman et al. (Tue,) studied this question.